ViaCyte, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 181
Rang # Quantité totale PI 7 253
Note d'activité PI 2,7/5.0    69
Rang # Activité PI 10 375
Classe Nice dominante Appareils et instruments médicaux

Brevets

Marques

112 6
35 3
21 2
2
 
Dernier brevet 2025 - Cell encapsulation devices with ...
Premier brevet 2002 - Methods for the culture of human...
Dernière marque 2015 - ENCAPTRA
Première marque 2010 - VIACYTE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof. Disclosed are cell ...
Invention Modulating inflammation associated with foreign body response. Disclosed herein include methods,...
Invention Endocrine cells that express chromogranin a. A human immature endocrine cell population and meth...
Invention Tools and instruments for use with implantable encapsulation devices. Embodiments herein describ...
Invention Cell encapsulation device comprising a pancreatic progenitor cell population. Disclosed herein a...
2023 Invention Anchor regions for implantable medical device. Devices for encapsulating biological entities (e.g...
Invention Implantable membrane construct and encapsulaton devices incorporating the same. An implantable me...
Invention Methods and compositions for feeder-free pluripotent stem cell media containing human serum. The...
Invention Universal donor cells and related methods. Disclosed herein are universal donor stem cells and c...
Invention Encapsulation of pancreatic cells derived from human pluripotent stem cells. The present inventi...
Invention Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof. Disclosed are cell e...
Invention Multilayer implantable cell encapsulation devices and methods thereof. Described is a multilayer...
Invention Multilayer implantable cell encapsulation devices and methods thereof. Described is a multilayer ...
2022 Invention Cryopreserved endocrine cells that express chromogranin a. A human immature endocrine cell popul...
Invention Methods of producing human foregut endoderm cells expressing pdx1 from human definitive endoderm....
Invention Methods of using pdx1-positive pancreatic endoderm cells and endocrine precursor cells. Disclosed...
2021 Invention Instruments and methods for loading cells into implantable devices. Embodiments herein describe t...
Invention Definitive endoderm. Disclosed herein are cell cultures comprising definitive endoderm cells and...
Invention 3-dimensional large capacity cell encapsulation device assembly. Disclosed herein are implantable...
Invention Tools and instruments for use with implantable encapsulation devices. Embodiments herein describe...
Invention Scalable primate pluripotent stem cell aggregate suspension culture. The present invention relate...
2020 Invention Cell encapsulation device comprising a pancreatic progenitor cell population. Disclosed herein ar...
Invention Methods and compositions for feeder-free pluripotent stem cell media containing human serum. The ...
Invention Cell encapsulation devices with controlled oxygen diffusion distances. Cell encapsulation devices...
Invention Biocompatible membrane composite. A biocompatible membrane composite including a cell impermeable...
Invention Cell encapsulation devices with controlled oxygen diffusion distances. Cell encapsulation device...
Invention A biocompatible membrane composite. A biocompatible mernbrane cornposite that can provide a...
Invention A biocompatible membrane composite. A biocompatible membrane composite including a first layer (c...
Invention A biocompatible membrane composite. in vivoe.g.e.g., point bonded or welded) or adhered (intimate...
Invention A biocompatible membrane composite. A biocompatible membrane composite including a cell impermeab...
Invention Cryopreservation and storage of an implantable encapsulation device loaded with an endocrine cell...
2019 Invention Methods of making human primitive ectoderm cells. This disclosure relates to compositions compris...
Invention Methods of producing pancreatic hormones. Disclosed herein are methods of producing pancreatic ho...
Invention Pdx1 positive foregut endoderm cells and methods of production. Disclosed herein are cell culture...
Invention Cryopreserved endocrine cells that express chromogranin a. A human immature endocrine cell popula...
Invention Methods of making and using pdx1-positive pancreatic endoderm cells. Disclosed herein are cell cu...
Invention Universal donor cells and related methods. Disclosed herein are universal donor stem cells and ce...
Invention Cryopreserved in vitro cell culture of human pancreatic progenitor cells. The present invention r...
2018 Invention Anterior endoderm cells and methods of production. Disclosed herein are cell cultures comprising ...
2016 Invention Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof. Disclosed are device...
2015 P/S Drug delivery device for medical use.
P/S Cells for scientific, laboratory or medical research. Therapeutic drug delivery device sold fille...
2014 P/S Cells for scientific, laboratory or medical research, namely pluripotent cells, endoderm cells, p...
P/S Drug delivery system, namely, subcutaneous implants for the delivery of drugs, cells, and therape...
P/S Therapeutic drug delivery device sold filled with cells for medical or clinical use
P/S Cells for medical or clinical use
2013 P/S Cells for scientific, laboratory or medical research Therapeutic drug delivery device sold filled...
2010 P/S Surgical, medical, dental and veterinary apparatus and instruments; devices for use in the admini...
P/S Chemicals used in science; biological preparations for use in cell cultures [other than medical];...
P/S Drug delivery systems
P/S Cells for scientific, laboratory or medical research